Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis C

Journal of Medical Virology

Volumn 46, Issue 2, 1995, Pages 109-115

  Orito, Etsuro ^a   Mizokami, Masashi ^a   Suzuki, Kaoru ^a   Ohba, Ken‐Ichi ^a   Ohno, Tomoyoshi ^a   Mori, Masamiki ^b   Hayashi, Katsuo ^b   Kato, Koji ^b   Iino, Shiro ^c   Lau, Johnson Y N ^d  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Nagoya City Higashi General Hospital   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

bDNA assay; HCV; HCV sero type; Interferon

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; SERODIAGNOSIS; SEROTYPE;

ADULT; AGED; ALANINE TRANSAMINASE; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RNA, VIRAL; TREATMENT OUTCOME;

HEPATITIS C VIRUS;

EID: 0029007330     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.1890460205     Document Type: Article

References (18)

1. Hepatitis C sero‐type and response to interferon therapy (letter)
2. Treatment of chronic hepatitis C with recombinant interferon alpha: A multicenter randomized, controlled trial
3. Quantitative detection of hepatitis C virus RNA with a solid‐phase signal amplification method Definition of optimal conditions for specimen collection and clinical application in interferon‐treated patients
4. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double‐blind, placebo‐controlled trial
5. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C
6. Long‐term carriage of hepatitis C virus with normal alanine aminotransferase after interferon treatment in patients with chronic hepatitis C
7. Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infection during and after therapy alpha interferon
8. Significance of serum hepatitis C virus RNA level in chronic hepatitis C
9. Discrepancy between biochemical and virological response to interferon‐α in chronic hepatitis C
10. Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infection
11. Serum hepatitis C virus RNA level as predictor of subsequent response to interferon‐α therapy in Japanese patients with chronic hepatitis C
12. Hepatitis C virus serotype II responds more favorable to interferon‐α therapy
13. 5′‐terminal sequences of the Hepatitis C virus genome
14. Significance of specific antibody assay for genotyping of hepatitis C virus
15. Antigenicities of group I and II hepatitis C virus polypeptides‐Molecular basis of diagnosis
16. A proposed system for the nomenclature for genotypes of hepatitis C virus
17. Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection of CMV, HBV, HCV and HIV
18. Detection of hepatitis C virus by polymerase chain reaction and response to interferon alfa therapy: Relationship to genotypes of hepatitis C virus